Medical Review (Aug 2022)

Adiponectin: friend or foe in obesity and inflammation

  • Luo Liping,
  • Liu Meilian

DOI
https://doi.org/10.1515/mr-2022-0002
Journal volume & issue
Vol. 2, no. 4
pp. 349 – 362

Abstract

Read online

Adiponectin is an adipokine predominantly produced by fat cells, circulates and exerts insulin-sensitizing, cardioprotective and anti-inflammatory effects. Dysregulation of adiponectin and/or adiponectin signaling is implicated in a number of metabolic diseases such as obesity, insulin resistance, diabetes, and cardiovascular diseases. However, while the insulin-sensitizing and cardioprotective effects of adiponectin have been widely appreciated in the field, the obesogenic and anti-inflammatory effects of adiponectin are still of much debate. Understanding the physiological function of adiponectin is critical for adiponectin-based therapeutics for the treatment of metabolic diseases.

Keywords